The cold agglutinin disease drugs market is estimated to be valued at USD 134 Mn in 2024 and is expected to reach USD 558 Mn by 2031, growing at a compound annual growth rate (CAGR) of 22.6% from 2024 to 2031. https://logcla.com/blogs/458086/Cold-Agglutinin-Disease-Drugs-Market-Projected-to-Witness-High-Growth